Log In
Print
BCIQ
Print
Print this Print this
 

Orencia, abatacept (ONO-4164IV)

Also known as: CTLA4-Ig (formerly BMS-188667IV)

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionCTLA-4-Ig fusion protein
Molecular Target CD80 (B7-1) ; CD86 (B7-2)
Mechanism of ActionImmune modulation
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today